Dr. Polina Khrizman, MD
- Medicare services, 2024
- 942
- Medicare patients, 2024
- 241
- Part D claims, 2024
- 614
- Publications
- 9
- Clinical trials
- 6
- Practice address
- 1 Cooper Plaza, Camden, NJ 08103
- Practice phone
- Call (856) 342-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Khrizman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Polina Khrizman is a hematologist and oncologist in Camden, New Jersey
Dr. Khrizman practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.
Dr. Khrizman's NPI, 1861673089, was assigned on November 15, 2007. Dr. Khrizman holds New Jersey license 25MA08921200.
- NPI
- 1861673089NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5890973556
- NPI enumeration date
- November 15, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (856) 342-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Polina Khrizman practices at Cooper University Hospital in Camden, New Jersey
Dr. Khrizman's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.
- Cooper University Hospital1 Cooper Plaza, Camden, NJ 08103 · Camden CountyPhone(856) 342-2000
Source: Dmand AI Affiliation Data
Dr. Polina Khrizman is affiliated with 5 sites of care and 1 medical group
Dr. Khrizman's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dr. Khrizman is also affiliated with Virtua Our Lady of Lourdes Hospital. The medical group on file is Cooper University Physicians. Dmand AI also links Dr. Khrizman to 2 more hospitals and 1 skilled nursing facility, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Polina Khrizman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khrizman practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Cooper University Hospital | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Cooper University Health Care and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Polina Khrizman is one of 364 hematologists and oncologists in New Jersey
Hematology and oncology is Dr. Khrizman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Khrizman's licenses on file in 2 states: New Jersey and Illinois.
Specialties and state licenses
- Hematology and oncology, New JerseyPrimary
- Internal medicine, Illinois
Hematologists and oncologists near Dr. Khrizman
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Polina Khrizman billed Medicare for 942 services in 2024
CMS data shows 942 Medicare services from Dr. Khrizman across 7 procedure codes in 2024, for 241 Medicare patients. Medicare paid $52,087 for them.
Dr. Khrizman's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 6572024: 54817%
- Other services
- 2023: 02024: 394
Where Dr. Khrizman's Medicare services took place, 2024
- In an office25527%
- In a facility68773%
Dr. Khrizman compared with the New Jersey median for hematologists and oncologists, 2024
- Dr. Khrizman
- New Jersey median
- Medicare services
- 942vs 1,51538% below
- Medicare patients
- 241vs 33728% below
- Part D claims
- 535vs 37842% above
Medians across 349 hematologists and oncologists in New Jersey with Dmand AI profiles that report each measure.
Dr. Khrizman's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Khrizman?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Khrizman and other hematologists and oncologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Polina Khrizman treated 241 Medicare patients in 2024, average age 71
CMS counts 241 Medicare patients who saw Dr. Khrizman in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Khrizman's median patient age at 66, with 56% women.
Dr. Khrizman's Medicare patients by age, 2024
Dr. Khrizman's Medicare patients by sex, 2024
- Women12251%
- Men11949%
Chronic conditions among Dr. Khrizman's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer63%
- Arthritis51%
- Diabetes38%
- Ischemic heart disease38%
- Anxiety37%
- COPD34%
Share of Medicare patients with each condition. A patient can have several.
Dr. Khrizman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women56%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Polina Khrizman wrote 614 Medicare Part D claims in 2024
In 2024, Dr. Khrizman wrote 614 Medicare Part D claims for 135 patients. 85% of them were for generic drugs. CMS names the drug for 535 of them, across 13 drugs with 11 or more claims each, at $625,909 in total drug cost. In 2023, CMS named 549 claims across 13 drugs.
Dr. Khrizman's Part D claims by kind of drug, 2024
- Generic521 claims85%
- Brand-name93 claims15%
Dr. Khrizman's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Khrizman's Part D claims, 2024
- Opioids3%17 of 614 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5492024: 5353%
Drugs named by CMS: 13 in 2024, 13 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Polina Khrizman scored 92 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Khrizman for performance year 2024, reported as part of a group. Dr. Khrizman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khrizman as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Khrizman's MIPS scores, performance year 2024
- 92of 100Final score
- 88.8of 100Quality
- 99of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Polina Khrizman has 9 publications on record
Dmand AI links 9 papers to Dr. Khrizman, published from 2010 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Radiosurgery, Neoadjuvant Therapy and Rectal Neoplasms. Dr. Khrizman's most frequent co-authors are Gregory Kubicek, MD, Richard D. Lackman, MD and Wissam B. Abouzgheib, MD.
Dr. Khrizman's papers by year, 2010 to 2024
Topics Dr. Khrizman writes about most
- Radiosurgery
- Neoadjuvant Therapy
- Rectal Neoplasms
Dr. Khrizman's most frequent co-authors
- Gregory Kubicek, MD3 shared papers
- Richard D. Lackman, MD2 shared papers
- Wissam B. Abouzgheib, MD1 shared paper
Recent publications by Dr. Khrizman
Clin Lung Cancer
See who Dr. Khrizman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Khrizman works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Polina Khrizman has worked on 6 clinical trials
Dmand AI links Dr. Khrizman to 6 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Sarcoma. National Cancer Institute (NCI) sponsors the most, 4.
Conditions in Dr. Khrizman's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Sarcoma
- Neoplasms, Connective and Soft Tissue
Investigators on the most trials with Dr. Khrizman
- Marta Batus, MD5 shared trials
- Nadeem Ikhlaque, MD5 shared trials
- Nisha Anjali Mohindra, MD5 shared trials
Recent clinical trials with Dr. Khrizman
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO) (opens in a new tab)
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (opens in a new tab)
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (opens in a new tab)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Polina Khrizman received $1,768 in industry payments from 2016 to 2025
CMS Open Payments shows 81 general payments to Dr. Khrizman from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Genentech, Inc. paid the most, $288.
General payments to Dr. Khrizman by program year, 2016 to 2025
General payments to Dr. Khrizman by kind, 2016 to 2025
- Food and beverage$1,49284%
- Education$27616%
Companies that paid Dr. Khrizman the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Polina Khrizman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Polina Khrizman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Polina Khrizman's NPI number?
Dr. Polina Khrizman's NPI number is 1861673089. It was assigned on November 15, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Polina Khrizman?
Dr. Polina Khrizman is a hematologist and oncologist in Camden, New Jersey. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Polina Khrizman practice?
Dr. Khrizman practices at 1 Cooper Plaza, Camden, NJ 08103. Dr. Khrizman's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dmand AI also links Dr. Khrizman to 2 hospitals and 1 skilled nursing facility.
What is Dr. Polina Khrizman's office phone number?
The practice phone on file for Dr. Khrizman is (856) 342-2000.
What is Dr. Polina Khrizman's medical license number?
Dr. Khrizman holds New Jersey license 25MA08921200, one of the licenses on file in 2 states.
Which states has Dr. Polina Khrizman been licensed in?
Dmand AI has state licenses on file for Dr. Khrizman in New Jersey and Illinois.
Which hospitals is Dr. Polina Khrizman affiliated with?
Dr. Khrizman practices at Cooper University Hospital in Camden, New Jersey. Dr. Khrizman is also affiliated with Virtua Our Lady of Lourdes Hospital. Dmand AI links Dr. Khrizman to 2 more hospitals.
What medical group is Dr. Polina Khrizman part of?
Dr. Khrizman is linked to Cooper University Physicians.
Does Dr. Polina Khrizman accept Medicare?
Yes. CMS data shows Dr. Khrizman billed Medicare for 942 services in 2024, and Dr. Khrizman accepts Medicare assignment.
Does Dr. Polina Khrizman offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Khrizman as offering telehealth services.
Show 8 more questionsShow fewer questions
What is Dr. Polina Khrizman's MIPS score?
Dr. Khrizman's MIPS final score for performance year 2024 is 92 out of 100, reported as part of a group.
How many Medicare patients does Dr. Polina Khrizman see?
CMS counts 241 Medicare patients who saw Dr. Khrizman in 2024, with an average age of 71.
What services does Dr. Polina Khrizman bill to Medicare?
In 2024, Dr. Khrizman's most billed Medicare services were medicare service (G2211), office visit, established patient (99213) and office visit, established patient (99215).
What drugs does Dr. Polina Khrizman prescribe most?
In 2024 Medicare Part D data, Dr. Khrizman's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron ODT and Dexamethasone.
Has Dr. Polina Khrizman received payments from drug or device companies?
CMS Open Payments shows $1,768 in general payments to Dr. Khrizman from 23 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Polina Khrizman been practicing?
Dr. Khrizman graduated from medical school in 2005, 21 years ago.
Does Dr. Polina Khrizman do research?
Dmand AI links 9 publications to Dr. Khrizman, published from 2010 to 2024. Dr. Khrizman has worked on 6 clinical trials.
Who does Dr. Polina Khrizman publish with?
Dr. Khrizman's most frequent co-authors are Gregory Kubicek, MD (3 shared papers), Richard D. Lackman, MD (2 shared papers) and Wissam B. Abouzgheib, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card